EFEKTIVITAS MENGONSUMSI OBAT ANTIRETROVIRAL DALAM MENURUNKAN ANGKA VIRAL LOAD PADA ODHA
Isi Artikel Utama
Abstrak
Human Immunodeficiency Virus (HIV) has infected many people throughout the world. In Indonesia alone, around 540,000 people have been infected with HIV and are living with Acquired Immunodeficiency Syndrome (AIDS). Until now, antiretroviral drug therapy (ARV) is the best choice which aims to reduce the risk of transmission, prevent worsening due to opportunistic infections, improve the quality of life of sufferers, and reduce the amount of virus (viral load) in the blood until it is undetectable. The aim of this study was to explain the effectiveness of taking ARV drugs in reducing viral load rates in patients at the Tulipe Clinic, M. Th. Hospital. Djaman, Sanggau Regency. This is a non-experimental quantitative research with a cross-sectional design. Sampling technique using purposive sampling, with the criteria applied, namely that respondents are ODHA or patients who have been diagnosed with HIV/AIDS, have undergone ARV therapy for at least six months, and are willing to become respondents so that a total of 89 people during 2022 – 2023 were obtained. The results of the study showed that the duration of taking ARVs ranged from 6 to 98 months, the viral load number was 14 - 35,400 copies/ml. The Spearman test obtained a significance value of 0.000 (p < 0.05), which means that taking ARV medication is effective in reducing viral load rates in Tulipe Clinic patients at M. Th. Hospital. Djaman, Sanggau Regency. Based on the results, it is expected that future studies can measure viral load along with molecular immunological parameters such as cytokine and antibody levels.
Rincian Artikel
Referensi
X. Tian et al., “Global, regional, and national HIV/AIDS disease burden levels and trends in 1990-2019: A systematic analysis for the global burden of disease 2019 study,” Front Public Health, vol. 11, p. 1068664, 2023, doi: 10.3389/fpubh.2023.1068664.
S. Q. Khairunisa et al., “Characterization of spatial and temporal transmission of HIV infection in Surabaya, Indonesia: Geographic information system (GIS) cluster detection analysis (2016-2020),” Heliyon, vol. 9, no. 9, p. e19528, Sep. 2023, doi: 10.1016/j.heliyon.2023.e19528.
UNAIDS, “HIV and AIDS in Indonesia,” 2022.. [Online]. Available: https://www.unaids.org/en/regionscountries/countries/indonesia
T. P. Merati et al., “Prevalence of HIV Infection and Resistance Mutations in Patients Hospitalized for Febrile Illness in Indonesia,” Am J Trop Med Hyg, vol. 105, no. 4, p. 960—965, Aug. 2021, doi: 10.4269/ajtmh.20-1595.
A. Dwi Elisanti, HIV-AIDS, Ibu Hamil dan Pencegahan Pada Janin. Sleman: Deepublish, 2020.
D. I. Novita, M. B. Karo, T. Tambaip, and E. A. Ekawati, “Prevalensi dan Karakteristik Pasien Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Di Kabupaten Merauke Periode Tahun 1992-2021,” Prosiding Pengabdian Kepada Masyarakat Poltekkes Kemenkes Tasikmalaya, vol. 2, no. 2, pp. 165–172, 2022.
G. Doitsh and W. C. Greene, “Dissecting How CD4 T Cells Are Lost During HIV Infection,” Cell host & microbe, vol. 19, no. 3, p. 280—291, Mar. 2016, doi: 10.1016/j.chom.2016.02.012.
K. K. Vidya Vijayan, K. P. Karthigeyan, S. P. Tripathi, and L. E. Hanna, “Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections,” Front Immunol, vol. 8, p. 580, 2017, doi: 10.3389/fimmu.2017.00580.
S. Govindaraj, H. Babu, S. Kannanganat, M. Vaccari, C. Petrovas, and V. Velu, “Editorial: CD4+ T cells in HIV: A Friend or a Foe?,” Front Immunol, vol. 14, p. 1203531, 2023, doi: 10.3389/fimmu.2023.1203531.
S. K. Masenga, B. C. Mweene, E. Luwaya, L. Muchaili, M. Chona, and A. Kirabo, “HIV-Host Cell Interactions,” Cells, vol. 12, no. 10, p. 1351, May 2023, doi: 10.3390/cells12101351.
A. A. Justiz Vaillant and P. G. Gulick, HIV and AIDS Syndrome. Treasure Island: StatPearls Publishing, Treasure Island (FL), 2023. [Online]. Available: http://europepmc.org/books/NBK534860
S. Lucas and A. M. Nelson, “HIV and the spectrum of human disease,” J Pathol, vol. 235, no. 2, p. 229—241, Jan. 2015, doi: 10.1002/path.4449.
R. S. Dauda, “Impact of HIV/aids epidemic on human capital development in West Africa,” Int J Health Plann Manage, vol. 33, no. 2, p. 460—478, Apr. 2018, doi: 10.1002/hpm.2486.
S. Wanni Arachchige Dona et al., “Added socioeconomic burden of non-communicable disease on HIV/AIDS affected households in the Asia Pacific region: A systematic review,” Lancet Reg Health West Pac, vol. 9, p. 100111, Apr. 2021, doi: 10.1016/j.lanwpc.2021.100111.
L. Berrezouga, I. Kooli, W. Marrakchi, G. Harzallah, and M. Chakroun, “Quality of Life of People Living with HIV on Antiretroviral Therapy: A Cross-Sectional Study in Monastir, Tunisia,” HIV AIDS (Auckl), vol. 15, p. 671—682, 2023, doi: 10.2147/hiv.s430376.
T. R. Kemnic and P. G. Gulick, HIV Antiretroviral Therapy. Treasure Island: StatPearls Publishing, Treasure Island (FL), 2023. [Online]. Available: http://europepmc.org/books/NBK513308
E. K. Hanners, J. Benitez-Burke, and M. E. Badowski, “HIV: how to manage low-level viraemia in people living with HIV,” Drugs Context, vol. 11, 2022, doi: 10.7573/dic.2021-8-13.
A. M. N. Tsibris and M. S. Hirsch, “130 - Antiretroviral Therapy for Human Immunodeficiency Virus Infection,” in Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases (Eighth Edition), J. E. Bennett, R. Dolin, and M. J. Blaser, Eds., Philadelphia: W.B. Saunders, 2015, pp. 1622-1641.e6. doi: https://doi.org/10.1016/B978-1-4557-4801-3.00130-2.
R. Siripurapu and Y. Ota, “Human Immunodeficiency Virus: Opportunistic Infections and Beyond,” Neuroimaging Clin N Am, vol. 33, no. 1, p. 147—165, Feb. 2023, doi: 10.1016/j.nic.2022.07.014.
T. H. Karyadi, “Keberhasilan Pengobatan Antiretroviral (ARV),” Jurnal Penyakit Dalam Indonesia, vol. 4, no. 1, pp. 1–3, 2017.
S. L. Lecher et al., “HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018,” MMWR Morb Mortal Wkly Rep, vol. 70, no. 21, p. 775—778, May 2021, doi: 10.15585/mmwr.mm7021a2.
Y. Limmade, L. Fransisca, R. Rodriguez-Fernandez, M. J. Bangs, and C. Rothe, “HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia,” PLoS One, vol. 14, no. 2, p. e0212432, 2019, doi: 10.1371/journal.pone.0212432.
H. Newman and D. Hardie, “HIV-1 viral load testing in resource-limited settings: Challenges and solutions for specimen integrity,” Rev Med Virol, vol. 31, no. 2, p. e2165, Mar. 2021, doi: 10.1002/rmv.2165.
A. Agegn Gwadu, M. Abebe Tegegne, K. Belay Mihretu, and A. S. Tegegne, “Predictors of Viral Load Status Over Time Among HIV Infected Adults Under HAART in Zewditu Memorial Hospital, Ethiopia: A Retrospective Study,” HIV AIDS (Auckl), vol. 15, p. 29—40, 2023, doi: 10.2147/hiv.s396030.
C. Zhou et al., “Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China,” Front Public Health, vol. 10, p. 800839, 2022, doi: 10.3389/fpubh.2022.800839.
D. Natalia, W. E. Susanti, and A. Mukarromah, “Infeksi Oportunistik pada Pasien Terinfeksi HIV di Rumah Sakit dr. Soedarso, Pontianak, Kalimantan Barat,” Majalah Kedokteran UKI, vol. 32, no. 2, pp. 60–66, 2016.
D. F. Ramadhan, “Hubungan dukungan keluarga dan kualitas hidup pasien hiv/aids yang menjalani rawat jalan di care support treatment rumah sakit jiwa daerah sungai bangkong,” Jurnal Mahasiswa PSPD FK Universitas Tanjungpura, vol. 4, no. 3, pp. 1127–1137, 2018.
M. Sajadipour et al., “What explains gender inequality in HIV infection among high-risk people? A Blinder-Oaxaca decomposition,” Arch Public Health, vol. 80, no. 1, p. 2, Jan. 2022, doi: 10.1186/s13690-021-00758-2.
M. A. Moonti, “Pengaruh Terapi Kognitif Untuk Menurunkan Kecemasan Terhadap Orang Dengan Hiv-Aids (ODHA) Di Kota Gorontalo,” Journal of Nursing Practice and Education, vol. 2, no. 02, pp. 90–98, 2022.
Kementerian Kesehatan RI, Peraturan Menteri Kesehatan Republik Indonesia Nomor 87 Tahun 2014 Tentang Pedoman Pengobatan Antiretroviral. Jakarta, Indonesia: Kementerian Kesehatan, 2015.
M. A. S. Putra and C. R. Sinaga, “Correlation Compliance Antiretroviral Therapy With Levels Viral Load In HIV Patients At Poly Clinic VCT Abdoel Wahab Sjahranie Samarinda Hospital 2022,” PHARMACON, vol. 12, no. 2, pp. 238–243, 2023.
S. A. Isnaini, A. Karyus, B. Setiaji, K. Pramudho, and E. Budiati, “Faktor yang Berhubungan dengan Kepatuhan Minum Obat ARV Pasien HIV Rawat Jalan,” Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, vol. 13, no. 4, pp. 1577–1586, 2023.
E. P. Yunita, S. Winarsih, and N. R. Deasury, “Pengaruh lama penggunaan kombinasi ARV (TDF+ 3TC+ EFV) terhadap jumlah sel CD4+ pasien HIV/AIDS,” Indonesian Journal of Clinical Pharmacy, vol. 9, no. 3, p. 219, 2020.
N. Dahliyanti, R. Khairiah, and F. Murtiani, “Hubungan Kepatuhan Antiretroviral Therapy Dengan Status Gizi Dan Kadar CD4 Pada Anak HIV/AIDS,” Jurnal Kesehatan Komunitas, vol. 8, no. 2, pp. 247–256, 2022.
M. S. Saag, “HIV 101: fundamentals of antiretroviral therapy,” Top Antivir Med, vol. 27, no. 3, p. 123—127, Sep. 2019, [Online]. Available: https://europepmc.org/articles/PMC6892619